Background. Mitotic arrest deficient 2 (Mad2) is a key component of spindle assembly checkpoint and overexpressed in human lung cancers, but the mechanism of the deregulation of Mad2 in lung cancer is largely unknown. We aim to investigate the regulation of Mad2 by S-phase kinase-associated protein 2 (Skp2) in human lung cancer cells.
24 Abstract 25 Background. Mitotic arrest deficient 2 (Mad2) is a key component of spindle assembly 26 checkpoint and overexpressed in human lung cancers, but the mechanism of the deregulation of 27 Mad2 in lung cancer is largely unknown. We aim to investigate the regulation of Mad2 by S-28 phase kinase-associated protein 2 (Skp2) in human lung cancer cells.
29 Methods. Human lung cancer A549 and NCI-H1975 cells were transfected with MAD2 and 30 SKP2 siRNAs or plasmids to silence or overexpress MAD2 and SKP2. Flavopiridol and 31 HLM006474 were used to inhibit cyclin dependent kinases (CDKs) and E2F1, respectively. 32 mRNA and protein levels were determined by real-time PCR and Western blot, respectively. 65 It was suggested that high-level Mad2 expression might be an independent prognostic factor for 66 NSCLC (Kato et al., 2011) . However, the mechanism by which Mad2 is deregulated in lung 67 cancer is largely unknown. 155 1A) . As expected, the Mad2 protein levels were drastically decreased by Skp2 siRNA (Fig. 1A ).
156 Consistent with the decrease of Mad2 protein, the mRNA levels of Mad2 were also significantly 157 downregulated by Skp2 siRNA in both A549 and NCI-H1975 cells (Fig. 1B) 166 hr in both A549 and NCI-H1975 cells (Fig. 1C) . The mRNA levels of Mad2 were also 167 significantly increased by pcDNA-SKP2 in both A549 and NCI-H1975 cells (Fig. 1D) . 
